R&D VisionMedMira is focused on developing new rapid tests using our patented rapid flow-through technology (RFT) platform and advancing the core product engine. In addition to MedMira’s own in-house product development efforts, our technology team also works with other companies in the diagnostics industry that seek rapid testing capabilities within a secure and unchallenged intellectual property framework. MedMira can perform technical conversions to RFT format from a wide variety of traditional platforms including ELISA and lateral flow. Post-development contract manufacturing in facilities that are GMP and ISO 13485 compliant is also available. MedMira continues to build a world class diagnostics pipeline based on our patented rapid flow-through technology platform.
MEDMIRA NAMED A 2008 TECH AWARDS LAUREATE |